Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Am J Public Health. 2015 Jan 20;105(7):1432–1438. doi: 10.2105/AJPH.2014.302287

TABLE 3.

Characteristics of B Classification Patients Who Received Full Clinical Evaluations, by Diagnosis Category: BCHD, Baltimore, MD, 2010–2012

Active TB (n = 6), No. (%) or Median (IQR) Latent TB (n = 76), No. (%) or Median (IQR) No TB Infection or Disease (n = 62), No. (%) or Median (IQR) P

B classification < .001
 B1 5/6 (83%) 39/76 (51%) 55/62 (89%)
 B2 1/6 (17%) 35/76 (46%) 7/62 (11%)
 B3 0/6 (0%) 2/76 (3%) 0/62 (0%)
Gender
 Female 1/6 (17%) 24/76 (32%) 26/62 (42%)
 Male 5/6 (83%) 52/76 (68%) 36/62 (58%)
Age, y 29 (14–30) 23 (12–49) 41 (27–59) .021
Country of origination/origin
 Other 0/6 (0%) 7/76 (9%) 10/62 (16%)
 Nepal/Bhutan 3/6 (50%) 50/76 (66%) 38/62 (61%)
 Philippines 0/6 (0%) 8/76 (11%) 11/62 (18%)
 Ethiopia/Eritrea 2/6 (33%) 6/76 (8%) 1/62 (2%)
 Dominican Republic 0/6 (0%) 2/76 (4%) 2/62 (3%)
 Turkey/Iraq 1/6 (17%) 3/76 (4%) 0/62 (0%)
History of prior TB noted in preimmigration paperwork 1/6 (17%) 4/76 (5%) 25/62 (40%) < .001
Days from entry to country to evaluation by BCHD 105 (63–125) 74 (53–98) 76 (57–98) .653
Abnormal preimmigration chest X-ray 5/6 (83%) 40/76 (53%) 55/62 (89%) < .001
 Infiltrate or consolidation 2/5 (40%) 5/40 (13%) 9/55 (16%)
 Any cavitary lesion 0/5 (0%) 0/40 (0%) 2/55 (4%)
 Nodule with poorly defined margins 0/5 (0%) 0/40 (0%) 2/55 (4%)
 Pleural effusion 0/5 (0%) 0/40 (0%) 0/55 (0%)
 Hilar mediastinal adenopathy 0/5 (0%) 1/40 (3%) 0/55 (0%)
 Linear interstitial markings 0/5 (0%) 0/40 (0%) 0/55 (0%)
 Discrete fibrotic scar or linear opacity 1/5 (20%) 24/40 (60%) 27/55 (49%)
 Discrete nodule without calcification 1/5 (20%) 3/40 (8%) 1/55 (2%)
 Discrete fibrotic scar with volume loss or retraction 1/5 (20%) 4/40 (10%) 3/55 (6%)
 Other 0/5 (0%) 3/40 (8%) 11/55 (20%)
Abnormal postimmigration chest X-ray 5/6 (83%) 23/75 (31%) 31/62 (50%) < .001
Reported symptoms 2/6 (33%) 9/76 (12%) 9/62 (15%)
 Received sputa testing 2/2 (100%) 8/9 (89%) 7/9 (78%)
 Culture positive 1/2 (50%) 0/8 (0%) 0/7 (0%)
Did not report symptoms 4/6 (67%) 67/76 (88%) 53/62 (86%)
 Received sputa testing 4/4 (100%) 17/67 (25%) 21/53 (43%)
 Culture positive 2/4 (50%) 0/17 (0%) 0/21 (0%)
Completed treatment 6/6 (100%) 60/66 (91%)

Note. BCHD = Baltimore City Health Department; IQR = interquartile range. P values presented in this table represent comparison between diagnosis categories for each variable. Patients received sputum testing on the basis of postimmigration chest X-ray, clinical history, or physical exam.